These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2056331)

  • 1. Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.
    Lange KW; Wells FR; Rossor MN; Jenner P; Marsden CD
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):373-4. PubMed ID: 2056331
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ; Martino AM; Antuono PG; Lowenstein PR; Coyle JT; Price DL; Kellar KJ
    Brain Res; 1986 Apr; 371(1):146-51. PubMed ID: 3708340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of the cholinergic system.
    Geroldi C; Bianchetti A; Trabucchi M
    Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
    [No Abstract]   [Full Text] [Related]  

  • 4. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.
    Mesulam MM
    Prog Brain Res; 1996; 109():285-97. PubMed ID: 9009717
    [No Abstract]   [Full Text] [Related]  

  • 5. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ; Martino AM; Marcus KA; Zweig RM; Singer HS; Price DL; Kellar KJ
    Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic receptor abnormalities in Alzheimer's disease.
    Court J; Martin-Ruiz C; Piggott M; Spurden D; Griffiths M; Perry E
    Biol Psychiatry; 2001 Feb; 49(3):175-84. PubMed ID: 11230868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on Alzheimer's disease and the animal disease model--special reference to acetylcholinergic system].
    Ueki A; Taira H; Miyoshi I
    Seishin Shinkeigaku Zasshi; 1989; 91(10):736-50. PubMed ID: 2626496
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
    Araujo DM; Lapchak PA
    Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH defects in Alzheimer's and other neurologic diseases.
    de Souza EB
    Hosp Pract (Off Ed); 1988 Sep; 23(9):59-71. PubMed ID: 2901426
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease and the cytoskeleton.
    Weber M
    Biochimie; 1986 Apr; 68(4):593-5. PubMed ID: 2427126
    [No Abstract]   [Full Text] [Related]  

  • 12. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease.
    Lapchak PA
    Exp Neurol; 1993 Nov; 124(1):16-20. PubMed ID: 8282073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
    Nordberg A; Alafuzoff I; Winblad B
    J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease and Alzheimer's disease: new neurochemical parallels.
    Whitehouse PJ
    Mov Disord; 1989; 4 Suppl 1():S57-62. PubMed ID: 2786144
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease.
    Wurtman RJ
    Sci Am; 1985 Jan; 252(1):62-6, 71-4. PubMed ID: 3880616
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
    Dani JA; Bertrand D
    Annu Rev Pharmacol Toxicol; 2007; 47():699-729. PubMed ID: 17009926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.
    Mann DM; Yates PO
    J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):936. PubMed ID: 7143014
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA; Nemeroff CB; Bissette G; Seidler FJ
    J Clin Invest; 1994 Aug; 94(2):696-702. PubMed ID: 8040324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of dementia.
    Plum F
    Gerontology; 1986; 32 Suppl 1():67-72. PubMed ID: 3732820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.